Precision BioSciences Inc (DTIL)
7.26
+0.76
(+11.69%)
USD |
NASDAQ |
Nov 22, 14:28
Precision BioSciences Total Assets (Quarterly): 153.26M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 153.26M |
| June 30, 2024 | 165.80M |
| March 31, 2024 | 184.74M |
| December 31, 2023 | 159.78M |
| September 30, 2023 | 164.34M |
| June 30, 2023 | 181.70M |
| March 31, 2023 | 204.50M |
| December 31, 2022 | 238.17M |
| September 30, 2022 | 271.73M |
| June 30, 2022 | 297.16M |
| March 31, 2022 | 181.35M |
| December 31, 2021 | 211.50M |
| Date | Value |
|---|---|
| September 30, 2021 | 227.20M |
| June 30, 2021 | 230.11M |
| March 31, 2021 | 262.32M |
| December 31, 2020 | 150.16M |
| September 30, 2020 | 168.69M |
| June 30, 2020 | 184.19M |
| March 31, 2020 | 214.20M |
| December 31, 2019 | 235.23M |
| September 30, 2019 | 260.30M |
| June 30, 2019 | 271.92M |
| March 31, 2019 | 166.80M |
| December 31, 2018 | 138.60M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
150.16M
Minimum
Dec 2020
297.16M
Maximum
Jun 2022
204.31M
Average
194.62M
Median
Total Assets (Quarterly) Benchmarks
| Pfizer Inc | 219.48B |
| Assembly Biosciences Inc | 100.26M |
| Protagonist Therapeutics Inc | 603.86M |
| Alector Inc | 516.02M |
| Entrada Therapeutics Inc | 554.59M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 88.39M |
| Shareholders Equity (Quarterly) | 64.87M |
| Debt to Equity Ratio | 0.3434 |
| Current Ratio | 9.224 |
| Net Debt Paydown Yield | 0.01% |